Terms: = Lung cancer AND AKT2, PKBBETA, 208, ENSG00000105221, RAC-BETA, P31751, PRKBB AND Clinical Outcome
10 results:
1. Interstitial lung Abnormalities in Patients With Locally Advanced Esophageal cancer: Prevalence, Risk Factors, and clinical Implications.
Tseng SC; Hino T; Hatabu H; Park H; Sanford NN; Lin G; Nishino M; Mamon H
J Comput Assist Tomogr; 2022 Nov-Dec 01; 46(6):871-877. PubMed ID: 35995596
[TBL] [Abstract] [Full Text] [Related]
2. Growth and clinical Impact of 6-mm or Larger Subsolid Nodules after 5 Years of Stability at Chest CT.
Lee JH; Lim WH; Hong JH; Nam JG; Hwang EJ; Kim H; Goo JM; Park CM
Radiology; 2020 May; 295(2):448-455. PubMed ID: 32181731
[TBL] [Abstract] [Full Text] [Related]
3. AKT1 and akt2 isoforms play distinct roles during breast cancer progression through the regulation of specific downstream proteins.
Riggio M; Perrone MC; Polo ML; Rodriguez MJ; May M; Abba M; Lanari C; Novaro V
Sci Rep; 2017 Mar; 7():44244. PubMed ID: 28287129
[TBL] [Abstract] [Full Text] [Related]
4. Prognostic impact of CD204-positive macrophages in lung squamous cell carcinoma: possible contribution of Cd204-positive macrophages to the tumor-promoting microenvironment.
Hirayama S; Ishii G; Nagai K; Ono S; Kojima M; Yamauchi C; Aokage K; Hishida T; Yoshida J; Suzuki K; Ochiai A
J Thorac Oncol; 2012 Dec; 7(12):1790-1797. PubMed ID: 23154550
[TBL] [Abstract] [Full Text] [Related]
5. Pharmacogenetic study of patients with advanced non-small cell lung cancer (NSCLC) treated with second-line pemetrexed or pemetrexed-carboplatin.
Tiseo M; Giovannetti E; Tibaldi C; Camerini A; Di Costanzo F; Barbieri F; Burgers JA; Vincent A; Peters GJ; Smit EF; Ardizzoni A
Lung Cancer; 2012 Oct; 78(1):92-9. PubMed ID: 22889494
[TBL] [Abstract] [Full Text] [Related]
6. [Expression and prognostic value of akt2 in non-small cell lung cancer].
Miao X; Song Y; Lv T; Zhan P; Lv Y; Yuan D
Zhongguo Fei Ai Za Zhi; 2011 May; 14(5):396-9. PubMed ID: 21569643
[TBL] [Abstract] [Full Text] [Related]
7. High frequency of frameshift mutation on p53 gene in Taiwanese with non small cell lung cancer.
Chang MY; Chong IW; Chen FM; Wang JY; Cheng TL; Cheng YJ; Sheu CC; Hung SY; Yang MC; Lin SR
Cancer Lett; 2005 May; 222(2):195-204. PubMed ID: 15863268
[TBL] [Abstract] [Full Text] [Related]
8. Staging small cell lung cancer: Veterans Administration lung Study Group versus International Association for the Study of lung cancer--what limits limited disease?
Micke P; Faldum A; Metz T; Beeh KM; Bittinger F; Hengstler JG; Buhl R
Lung Cancer; 2002 Sep; 37(3):271-6. PubMed ID: 12234695
[TBL] [Abstract] [Full Text] [Related]
9. Prognostic significance of cyclin D1 and retinoblastoma expression in combination with p53 abnormalities in primary, resected non-small cell lung cancers.
Nishio M; Koshikawa T; Yatabe Y; Kuroishi T; Suyama M; Nagatake M; Sugiura T; Ariyoshi Y; Mitsudomi T; Takahashi T
Clin Cancer Res; 1997 Jul; 3(7):1051-8. PubMed ID: 9815783
[TBL] [Abstract] [Full Text] [Related]
10. Prognostic significance of abnormal p53 accumulation in primary, resected non-small-cell lung cancers.
Nishio M; Koshikawa T; Kuroishi T; Suyama M; Uchida K; Takagi Y; Washimi O; Sugiura T; Ariyoshi Y; Takahashi T; Ueda R; Takahashi T
J Clin Oncol; 1996 Feb; 14(2):497-502. PubMed ID: 8636763
[TBL] [Abstract] [Full Text] [Related]
